483
Havix Group IncFDA 483 - Havix Group Inc - April 19, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Havix Group Inc d/b/a Aavis Pharmaceuticals, a drug manufacturer in Hoschton, GA, was cited for two observations during an FDA inspection. The firm failed to exercise appropriate controls over computer systems, allowing unauthorized personnel administrator rights, and lacked established procedures to prevent objectionable microorganisms. Specifically, issues were noted with cleaning validation for non-dedicated equipment and clean equipment hold times.
Open in Dashboard
ID · b1d66927-f26b-40df-ab88-400a83acfcfa